

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 8.26064352 |
| 2 | negative thymic T cell selection (GO:0045060) | 7.81879529 |
| 3 | regulation of isotype switching to IgG isotypes (GO:0048302) | 7.65926511 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.55426024 |
| 5 | positive thymic T cell selection (GO:0045059) | 7.27593883 |
| 6 | positive T cell selection (GO:0043368) | 7.13653769 |
| 7 | interferon-gamma production (GO:0032609) | 7.10482890 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.79505791 |
| 9 | cellular response to interleukin-15 (GO:0071350) | 6.79084573 |
| 10 | thymic T cell selection (GO:0045061) | 6.72584445 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.52328738 |
| 12 | negative regulation of cell killing (GO:0031342) | 6.52328738 |
| 13 | response to interleukin-15 (GO:0070672) | 6.36914984 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.34923232 |
| 15 | T cell selection (GO:0045058) | 6.27190077 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.10338779 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.10338779 |
| 18 | leukocyte aggregation (GO:0070486) | 5.74576803 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 5.74411390 |
| 20 | * T cell receptor signaling pathway (GO:0050852) | 5.67939325 |
| 21 | regulation of T cell tolerance induction (GO:0002664) | 5.60558787 |
| 22 | T cell costimulation (GO:0031295) | 5.54782855 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.52921602 |
| 24 | T cell migration (GO:0072678) | 5.52493346 |
| 25 | lymphocyte costimulation (GO:0031294) | 5.51336922 |
| 26 | sequestering of actin monomers (GO:0042989) | 5.11741209 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.98012874 |
| 28 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.86997362 |
| 29 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.62895304 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.55262582 |
| 31 | positive regulation of tolerance induction (GO:0002645) | 4.53096989 |
| 32 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.48691015 |
| 33 | positive regulation of isotype switching (GO:0045830) | 4.43444746 |
| 34 | regulation of isotype switching (GO:0045191) | 4.33605714 |
| 35 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.33155181 |
| 36 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.27369435 |
| 37 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.27255946 |
| 38 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.27255946 |
| 39 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.25384032 |
| 40 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.24825709 |
| 41 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.24825709 |
| 42 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.18771062 |
| 43 | cytidine deamination (GO:0009972) | 4.14907205 |
| 44 | cytidine metabolic process (GO:0046087) | 4.14907205 |
| 45 | cytidine catabolic process (GO:0006216) | 4.14907205 |
| 46 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.13250773 |
| 47 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 4.05939949 |
| 48 | regulation of response to interferon-gamma (GO:0060330) | 4.05334032 |
| 49 | positive regulation of DNA recombination (GO:0045911) | 4.01144825 |
| 50 | B cell receptor signaling pathway (GO:0050853) | 3.98119574 |
| 51 | regulation of B cell differentiation (GO:0045577) | 3.97686481 |
| 52 | tolerance induction (GO:0002507) | 3.97049604 |
| 53 | mast cell activation (GO:0045576) | 3.96811170 |
| 54 | T cell differentiation (GO:0030217) | 3.94437682 |
| 55 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.92519694 |
| 56 | positive regulation of granulocyte differentiation (GO:0030854) | 3.91635877 |
| 57 | regulation of tolerance induction (GO:0002643) | 3.90337058 |
| 58 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.88459982 |
| 59 | alpha-beta T cell differentiation (GO:0046632) | 3.87555134 |
| 60 | activated T cell proliferation (GO:0050798) | 3.86403367 |
| 61 | positive regulation of interleukin-2 production (GO:0032743) | 3.85958755 |
| 62 | regulation of defense response to virus by virus (GO:0050690) | 3.82159250 |
| 63 | positive regulation of B cell mediated immunity (GO:0002714) | 3.80974041 |
| 64 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.80974041 |
| 65 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.79836700 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 3.75697600 |
| 67 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.75282693 |
| 68 | alpha-beta T cell activation (GO:0046631) | 3.72750968 |
| 69 | regulation of B cell mediated immunity (GO:0002712) | 3.72561027 |
| 70 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.71924309 |
| 71 | T cell activation (GO:0042110) | 3.70250994 |
| 72 | regulation of immunoglobulin production (GO:0002637) | 3.69967434 |
| 73 | regulation of regulatory T cell differentiation (GO:0045589) | 3.68439718 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.65199567 |
| 75 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.63570717 |
| 76 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.62639810 |
| 77 | positive regulation of immunoglobulin production (GO:0002639) | 3.61940204 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.56736681 |
| 79 | regulation of cell killing (GO:0031341) | 3.56175170 |
| 80 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.53166947 |
| 81 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.53166947 |
| 82 | T cell differentiation involved in immune response (GO:0002292) | 3.53166947 |
| 83 | positive regulation of cell killing (GO:0031343) | 3.52578569 |
| 84 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.49076475 |
| 85 | natural killer cell activation (GO:0030101) | 3.48299716 |
| 86 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.42861275 |
| 87 | T-helper cell differentiation (GO:0042093) | 3.42861275 |
| 88 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.41951514 |
| 89 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.40417734 |
| 90 | DNA deamination (GO:0045006) | 3.40121082 |
| 91 | negative regulation of T cell mediated immunity (GO:0002710) | 3.37772610 |
| 92 | immunoglobulin mediated immune response (GO:0016064) | 3.37653786 |
| 93 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.37510515 |
| 94 | regulation of interleukin-4 production (GO:0032673) | 3.28776317 |
| 95 | positive regulation of humoral immune response (GO:0002922) | 3.28045119 |
| 96 | leukocyte cell-cell adhesion (GO:0007159) | 3.26674052 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 3.22588073 |
| 98 | neutrophil activation (GO:0042119) | 3.18029123 |
| 99 | lymphocyte migration (GO:0072676) | 3.16401257 |
| 100 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.16221044 |
| 101 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.15897378 |
| 102 | positive regulation of T cell mediated immunity (GO:0002711) | 3.14867598 |
| 103 | positive regulation of T cell activation (GO:0050870) | 3.14594156 |
| 104 | signal peptide processing (GO:0006465) | 3.12546136 |
| 105 | V(D)J recombination (GO:0033151) | 3.11660497 |
| 106 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.10898495 |
| 107 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.10752264 |
| 108 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.09422117 |
| 109 | positive regulation of lamellipodium assembly (GO:0010592) | 3.09086395 |
| 110 | regulation of T cell mediated immunity (GO:0002709) | 3.08662793 |
| 111 | positive regulation of defense response to virus by host (GO:0002230) | 3.08472024 |
| 112 | positive regulation of interleukin-4 production (GO:0032753) | 3.08076037 |
| 113 | detection of bacterium (GO:0016045) | 3.07982812 |
| 114 | T cell homeostasis (GO:0043029) | 3.07960277 |
| 115 | response to type I interferon (GO:0034340) | 3.07953446 |
| 116 | regulation of alpha-beta T cell activation (GO:0046634) | 3.07420291 |
| 117 | granulocyte activation (GO:0036230) | 3.06719080 |
| 118 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.05026668 |
| 119 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.04419849 |
| 120 | heterotypic cell-cell adhesion (GO:0034113) | 3.04329736 |
| 121 | cellular response to type I interferon (GO:0071357) | 3.04288388 |
| 122 | type I interferon signaling pathway (GO:0060337) | 3.04288388 |
| 123 | dendritic cell chemotaxis (GO:0002407) | 3.01900124 |
| 124 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.00930540 |
| 125 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.99832330 |
| 126 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.99753202 |
| 127 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.99147458 |
| 128 | Peyers patch development (GO:0048541) | 2.99147458 |
| 129 | cellular defense response (GO:0006968) | 2.97489354 |
| 130 | B cell mediated immunity (GO:0019724) | 2.97266661 |
| 131 | neutrophil activation involved in immune response (GO:0002283) | 2.93950392 |
| 132 | regulation of antigen processing and presentation (GO:0002577) | 2.93295804 |
| 133 | negative regulation of T cell apoptotic process (GO:0070233) | 2.93063803 |
| 134 | natural killer cell differentiation (GO:0001779) | 2.92037855 |
| 135 | detection of other organism (GO:0098543) | 2.90081156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.37956771 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.16662490 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.32596527 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.15872763 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.78305297 |
| 6 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.63209025 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.61708050 |
| 8 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.60503384 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.60139315 |
| 10 | * MYB_26560356_Chip-Seq_TH2_Human | 3.38051050 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 3.10070293 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.06934900 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94271456 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.85039928 |
| 15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.78095450 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73533875 |
| 17 | * MYB_26560356_Chip-Seq_TH1_Human | 2.71793152 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.51311950 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.50145664 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.50036649 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49758095 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.38709239 |
| 23 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.30455493 |
| 24 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.26069995 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.26048751 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22145617 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 2.06899944 |
| 28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93642439 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92167450 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91469858 |
| 31 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.75437652 |
| 32 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73969327 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.69183514 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.65314477 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64097206 |
| 36 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62926828 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62304805 |
| 38 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.56423742 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.55129203 |
| 40 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.54217816 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52091467 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.46365325 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.44678939 |
| 44 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43593660 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42627779 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41517053 |
| 47 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40879156 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39936803 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37406052 |
| 50 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.35760810 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34355101 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33817126 |
| 53 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.32275845 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.31697386 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31175861 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.30956794 |
| 57 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.25009306 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23180643 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23127598 |
| 60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22712614 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21238491 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.20257570 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19892702 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19653341 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18671111 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15508945 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14800648 |
| 68 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.14619873 |
| 69 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.13247100 |
| 70 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.12467623 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08815141 |
| 72 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08557479 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07387646 |
| 74 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06585005 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04750582 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03700916 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02727603 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02549260 |
| 79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02434367 |
| 80 | GATA3_26560356_Chip-Seq_TH1_Human | 1.02108627 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01852078 |
| 82 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01384556 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01229630 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00617554 |
| 85 | P300_27268052_Chip-Seq_Bcells_Human | 1.00486847 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00309158 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00147424 |
| 88 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99640941 |
| 89 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.98559663 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98399426 |
| 91 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94459558 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94442897 |
| 93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94246311 |
| 94 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.89584863 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89030975 |
| 96 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88513231 |
| 97 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.88488089 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87660548 |
| 99 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86518921 |
| 100 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85620300 |
| 101 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85217104 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84922374 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83543147 |
| 104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83169732 |
| 105 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.82919869 |
| 106 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.82901222 |
| 107 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82897273 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82782162 |
| 109 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81401247 |
| 110 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79522504 |
| 111 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79422405 |
| 112 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77980490 |
| 113 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77587302 |
| 114 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.76269456 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76239177 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75764515 |
| 117 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.75532859 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73742007 |
| 119 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.73242495 |
| 120 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73231422 |
| 121 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.73030987 |
| 122 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72873568 |
| 123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72024685 |
| 124 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.71779966 |
| 125 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.70541628 |
| 126 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.69916279 |
| 127 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.68051373 |
| 128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.67601103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.40984696 |
| 2 | MP0005671_abnormal_response_to | 5.71144845 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.42364377 |
| 4 | MP0000685_abnormal_immune_system | 3.41582307 |
| 5 | MP0002166_altered_tumor_susceptibility | 3.30066028 |
| 6 | MP0001800_abnormal_humoral_immune | 3.10525563 |
| 7 | MP0009333_abnormal_splenocyte_physiolog | 3.10360448 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.91460851 |
| 9 | MP0000703_abnormal_thymus_morphology | 2.90724612 |
| 10 | * MP0002420_abnormal_adaptive_immunity | 2.86516148 |
| 11 | * MP0001819_abnormal_immune_cell | 2.83168860 |
| 12 | MP0006082_CNS_inflammation | 2.83058559 |
| 13 | MP0002006_tumorigenesis | 2.82403060 |
| 14 | * MP0002398_abnormal_bone_marrow | 2.81394844 |
| 15 | MP0009785_altered_susceptibility_to | 2.81219937 |
| 16 | * MP0002723_abnormal_immune_serum | 2.77555787 |
| 17 | * MP0005387_immune_system_phenotype | 2.56926599 |
| 18 | * MP0001790_abnormal_immune_system | 2.56926599 |
| 19 | MP0002405_respiratory_system_inflammati | 2.55017721 |
| 20 | * MP0000716_abnormal_immune_system | 2.46609852 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.45635928 |
| 22 | MP0005025_abnormal_response_to | 2.38796453 |
| 23 | MP0002722_abnormal_immune_system | 2.36701342 |
| 24 | MP0003724_increased_susceptibility_to | 2.35783427 |
| 25 | MP0001873_stomach_inflammation | 2.22261778 |
| 26 | MP0002933_joint_inflammation | 2.17774012 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.15843353 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.09986485 |
| 29 | MP0004947_skin_inflammation | 2.06519580 |
| 30 | MP0005310_abnormal_salivary_gland | 2.06280685 |
| 31 | MP0003866_abnormal_defecation | 2.05668652 |
| 32 | * MP0002429_abnormal_blood_cell | 1.96877815 |
| 33 | MP0003436_decreased_susceptibility_to | 1.91597366 |
| 34 | MP0004381_abnormal_hair_follicle | 1.76772366 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.75202342 |
| 36 | MP0003303_peritoneal_inflammation | 1.72832710 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.71513252 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.68348824 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.66064767 |
| 40 | MP0002419_abnormal_innate_immunity | 1.57707551 |
| 41 | MP0002693_abnormal_pancreas_physiology | 1.54248335 |
| 42 | MP0000858_altered_metastatic_potential | 1.53430272 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.51859192 |
| 44 | MP0004510_myositis | 1.46721554 |
| 45 | MP0002009_preneoplasia | 1.35693019 |
| 46 | MP0002132_abnormal_respiratory_system | 1.34152879 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.31109090 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.20522896 |
| 49 | MP0008469_abnormal_protein_level | 1.05698872 |
| 50 | MP0001986_abnormal_taste_sensitivity | 1.05219995 |
| 51 | MP0002019_abnormal_tumor_incidence | 1.04894538 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.04005325 |
| 53 | MP0003448_altered_tumor_morphology | 1.03549700 |
| 54 | MP0000490_abnormal_crypts_of | 1.03135346 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 0.99712061 |
| 56 | MP0008961_abnormal_basal_metabolism | 0.99383539 |
| 57 | MP0002909_abnormal_adrenal_gland | 0.98633021 |
| 58 | MP0001533_abnormal_skeleton_physiology | 0.96156455 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 0.93795513 |
| 60 | MP0003045_fibrosis | 0.92306339 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 0.91318386 |
| 62 | MP0001853_heart_inflammation | 0.88368006 |
| 63 | MP0001944_abnormal_pancreas_morphology | 0.86288634 |
| 64 | MP0001851_eye_inflammation | 0.85175631 |
| 65 | MP0003693_abnormal_embryo_hatching | 0.84516854 |
| 66 | MP0002998_abnormal_bone_remodeling | 0.84198641 |
| 67 | MP0002163_abnormal_gland_morphology | 0.83408138 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 0.74706715 |
| 69 | MP0000613_abnormal_salivary_gland | 0.74079592 |
| 70 | MP0001663_abnormal_digestive_system | 0.72818258 |
| 71 | MP0004957_abnormal_blastocyst_morpholog | 0.70935677 |
| 72 | MP0002928_abnormal_bile_duct | 0.70444040 |
| 73 | MP0008057_abnormal_DNA_replication | 0.70170960 |
| 74 | MP0000013_abnormal_adipose_tissue | 0.68525710 |
| 75 | MP0003795_abnormal_bone_structure | 0.66937785 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 0.66347920 |
| 77 | MP0009765_abnormal_xenobiotic_induced | 0.65803549 |
| 78 | MP0003787_abnormal_imprinting | 0.64642887 |
| 79 | MP0009763_increased_sensitivity_to | 0.62073978 |
| 80 | MP0000569_abnormal_digit_pigmentation | 0.61064088 |
| 81 | MP0003806_abnormal_nucleotide_metabolis | 0.60842659 |
| 82 | MP0001348_abnormal_lacrimal_gland | 0.58886315 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.58531571 |
| 84 | MP0008877_abnormal_DNA_methylation | 0.58117020 |
| 85 | MP0008058_abnormal_DNA_repair | 0.56737654 |
| 86 | MP0003077_abnormal_cell_cycle | 0.56720814 |
| 87 | MP0000372_irregular_coat_pigmentation | 0.56464457 |
| 88 | MP0000477_abnormal_intestine_morphology | 0.56440954 |
| 89 | MP0008872_abnormal_physiological_respon | 0.55534708 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.55125765 |
| 91 | MP0000249_abnormal_blood_vessel | 0.54873662 |
| 92 | MP0004883_abnormal_blood_vessel | 0.54420328 |
| 93 | MP0001243_abnormal_dermal_layer | 0.54160527 |
| 94 | MP0005166_decreased_susceptibility_to | 0.53357674 |
| 95 | MP0008007_abnormal_cellular_replicative | 0.52645755 |
| 96 | MP0008873_increased_physiological_sensi | 0.52618481 |
| 97 | MP0003252_abnormal_bile_duct | 0.51918666 |
| 98 | MP0005390_skeleton_phenotype | 0.51911670 |
| 99 | MP0000678_abnormal_parathyroid_gland | 0.51716521 |
| 100 | MP0003786_premature_aging | 0.51500716 |
| 101 | MP0003646_muscle_fatigue | 0.51384849 |
| 102 | MP0006072_abnormal_retinal_apoptosis | 0.50691150 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.50348090 |
| 104 | MP0002876_abnormal_thyroid_physiology | 0.50221713 |
| 105 | MP0008260_abnormal_autophagy | 0.49970741 |
| 106 | MP0002277_abnormal_respiratory_mucosa | 0.47587349 |
| 107 | MP0001919_abnormal_reproductive_system | 0.46573597 |
| 108 | MP0006292_abnormal_olfactory_placode | 0.46274359 |
| 109 | MP0004130_abnormal_muscle_cell | 0.46191909 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.45936827 |
| 111 | MP0000609_abnormal_liver_physiology | 0.45710410 |
| 112 | MP0000313_abnormal_cell_death | 0.45709376 |
| 113 | MP0002136_abnormal_kidney_physiology | 0.45245282 |
| 114 | MP0005023_abnormal_wound_healing | 0.44437427 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 0.44197518 |
| 116 | MP0002095_abnormal_skin_pigmentation | 0.42823229 |
| 117 | MP0003191_abnormal_cellular_cholesterol | 0.42576740 |
| 118 | MP0010386_abnormal_urinary_bladder | 0.42173995 |
| 119 | MP0003959_abnormal_lean_body | 0.42019486 |
| 120 | MP0005451_abnormal_body_composition | 0.40701587 |
| 121 | MP0009764_decreased_sensitivity_to | 0.40641339 |
| 122 | MP0009278_abnormal_bone_marrow | 0.40498869 |
| 123 | MP0008874_decreased_physiological_sensi | 0.40261888 |
| 124 | MP0000604_amyloidosis | 0.40137560 |
| 125 | MP0005174_abnormal_tail_pigmentation | 0.40134272 |
| 126 | MP0010094_abnormal_chromosome_stability | 0.40086663 |
| 127 | MP0003075_altered_response_to | 0.39910875 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.39878753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 8.71102814 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.33132366 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 7.38456122 |
| 4 | Combined immunodeficiency (HP:0005387) | 6.98197288 |
| 5 | Abnormality of T cells (HP:0002843) | 6.01442730 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.68637159 |
| 7 | Recurrent bronchitis (HP:0002837) | 5.52359893 |
| 8 | IgG deficiency (HP:0004315) | 5.20865900 |
| 9 | Hypoplasia of the thymus (HP:0000778) | 4.92434655 |
| 10 | Stomatitis (HP:0010280) | 4.73557610 |
| 11 | Thyroiditis (HP:0100646) | 4.70289957 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 4.62539485 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.62539485 |
| 14 | Increased IgM level (HP:0003496) | 4.50232010 |
| 15 | IgM deficiency (HP:0002850) | 4.37815188 |
| 16 | Autoimmune hemolytic anemia (HP:0001890) | 4.37755595 |
| 17 | Abnormality of eosinophils (HP:0001879) | 4.37450959 |
| 18 | Recurrent fungal infections (HP:0002841) | 4.36930058 |
| 19 | Chronic diarrhea (HP:0002028) | 4.36543051 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 4.30646634 |
| 21 | Nasal polyposis (HP:0100582) | 4.19022883 |
| 22 | Abnormality of B cell number (HP:0010975) | 4.09358869 |
| 23 | B lymphocytopenia (HP:0010976) | 4.09358869 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 3.87694863 |
| 25 | Abnormality of T cell physiology (HP:0011840) | 3.82682367 |
| 26 | Myositis (HP:0100614) | 3.75371906 |
| 27 | Recurrent viral infections (HP:0004429) | 3.63601113 |
| 28 | Bronchitis (HP:0012387) | 3.56702917 |
| 29 | Chronic otitis media (HP:0000389) | 3.56428820 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.56397383 |
| 31 | Lymphopenia (HP:0001888) | 3.54363029 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.48432235 |
| 33 | Eosinophilia (HP:0001880) | 3.47503716 |
| 34 | Leukocytosis (HP:0001974) | 3.41305147 |
| 35 | Abnormality of the nasal mucosa (HP:0000433) | 3.39159231 |
| 36 | Joint swelling (HP:0001386) | 3.39020868 |
| 37 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.37896309 |
| 38 | Abnormality of macrophages (HP:0004311) | 3.33346817 |
| 39 | Abnormality of the fingertips (HP:0001211) | 3.18690686 |
| 40 | Granulocytopenia (HP:0001913) | 3.05340852 |
| 41 | Optic neuritis (HP:0100653) | 3.00575403 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 3.00575403 |
| 43 | Papilloma (HP:0012740) | 2.96696498 |
| 44 | Verrucae (HP:0200043) | 2.96696498 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.84828806 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.77418316 |
| 47 | Recurrent sinusitis (HP:0011108) | 2.75944980 |
| 48 | Meningitis (HP:0001287) | 2.74927337 |
| 49 | Lymphoma (HP:0002665) | 2.74920346 |
| 50 | Pustule (HP:0200039) | 2.74832658 |
| 51 | Hemoptysis (HP:0002105) | 2.73588650 |
| 52 | Hypergammaglobulinemia (HP:0010702) | 2.70337239 |
| 53 | Colitis (HP:0002583) | 2.68982218 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.63463320 |
| 55 | Orchitis (HP:0100796) | 2.63387697 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.55004978 |
| 57 | Encephalitis (HP:0002383) | 2.48814008 |
| 58 | Cellulitis (HP:0100658) | 2.43799813 |
| 59 | Cheilitis (HP:0100825) | 2.43783371 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.42615249 |
| 61 | Vasculitis (HP:0002633) | 2.39776706 |
| 62 | Recurrent skin infections (HP:0001581) | 2.38540788 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.38509582 |
| 64 | Urticaria (HP:0001025) | 2.35090147 |
| 65 | IgA deficiency (HP:0002720) | 2.32246971 |
| 66 | Recurrent otitis media (HP:0000403) | 2.32085260 |
| 67 | Abnormality of the pleura (HP:0002103) | 2.27884940 |
| 68 | Bronchiectasis (HP:0002110) | 2.25488244 |
| 69 | Hypochromic anemia (HP:0001931) | 2.24044456 |
| 70 | Skin rash (HP:0000988) | 2.23399173 |
| 71 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.20084330 |
| 72 | Prostate neoplasm (HP:0100787) | 2.17353316 |
| 73 | Amyotrophic lateral sclerosis (HP:0007354) | 2.17089168 |
| 74 | Recurrent abscess formation (HP:0002722) | 2.15298935 |
| 75 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.14783218 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12890522 |
| 77 | Obstructive lung disease (HP:0006536) | 2.12890522 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 2.11795468 |
| 79 | Basal cell carcinoma (HP:0002671) | 2.08738640 |
| 80 | Sepsis (HP:0100806) | 2.07737835 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.05018656 |
| 82 | Stomach cancer (HP:0012126) | 2.03638118 |
| 83 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.02169352 |
| 84 | Neutropenia (HP:0001875) | 2.00415193 |
| 85 | Glomerulopathy (HP:0100820) | 1.96436552 |
| 86 | Gingival bleeding (HP:0000225) | 1.96325539 |
| 87 | Osteomyelitis (HP:0002754) | 1.96230356 |
| 88 | Recurrent pneumonia (HP:0006532) | 1.95681532 |
| 89 | Aplastic anemia (HP:0001915) | 1.94971910 |
| 90 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93060603 |
| 91 | Chronic sinusitis (HP:0011109) | 1.92166350 |
| 92 | Congenital stationary night blindness (HP:0007642) | 1.91861493 |
| 93 | Mediastinal lymphadenopathy (HP:0100721) | 1.86746985 |
| 94 | Microcytic anemia (HP:0001935) | 1.86003028 |
| 95 | Gingivitis (HP:0000230) | 1.85815454 |
| 96 | Renal cortical cysts (HP:0000803) | 1.84829505 |
| 97 | Keratoconjunctivitis (HP:0001096) | 1.82558459 |
| 98 | Spontaneous hematomas (HP:0007420) | 1.81315718 |
| 99 | Hypoproteinemia (HP:0003075) | 1.78140837 |
| 100 | Inflammation of the large intestine (HP:0002037) | 1.75992292 |
| 101 | Ureteral stenosis (HP:0000071) | 1.74778568 |
| 102 | Anorexia (HP:0002039) | 1.73344979 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 1.72835710 |
| 104 | Abnormality of the endocardium (HP:0004306) | 1.71029493 |
| 105 | Entropion (HP:0000621) | 1.70484513 |
| 106 | Ureteral obstruction (HP:0006000) | 1.67345502 |
| 107 | Poikiloderma (HP:0001029) | 1.65916081 |
| 108 | Menstrual irregularities (HP:0000858) | 1.65575414 |
| 109 | Keratitis (HP:0000491) | 1.65214720 |
| 110 | Increased IgE level (HP:0003212) | 1.64930929 |
| 111 | Abnormality of the prostate (HP:0008775) | 1.64532429 |
| 112 | Gangrene (HP:0100758) | 1.62899999 |
| 113 | Abnormality of the thymus (HP:0000777) | 1.60485499 |
| 114 | Arterial thrombosis (HP:0004420) | 1.59251444 |
| 115 | Muscle fiber atrophy (HP:0100295) | 1.57627723 |
| 116 | Epistaxis (HP:0000421) | 1.57353686 |
| 117 | Cellular immunodeficiency (HP:0005374) | 1.56155428 |
| 118 | Prominent metopic ridge (HP:0005487) | 1.54811506 |
| 119 | Chest pain (HP:0100749) | 1.54748429 |
| 120 | Type 2 muscle fiber atrophy (HP:0003554) | 1.54268361 |
| 121 | Polyneuropathy (HP:0001271) | 1.54162578 |
| 122 | Pulmonary embolism (HP:0002204) | 1.53667415 |
| 123 | Acute hepatic failure (HP:0006554) | 1.52816622 |
| 124 | Petechiae (HP:0000967) | 1.52033512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.05611876 |
| 2 | MAP4K1 | 5.56514001 |
| 3 | ZAP70 | 3.90902578 |
| 4 | ITK | 3.43398097 |
| 5 | JAK3 | 3.12889592 |
| 6 | FGFR4 | 3.06085910 |
| 7 | KDR | 3.02877166 |
| 8 | RIPK4 | 3.00010813 |
| 9 | IKBKE | 2.89477893 |
| 10 | NLK | 2.47796465 |
| 11 | TESK2 | 2.21761728 |
| 12 | STK10 | 2.11287812 |
| 13 | TYK2 | 2.09853252 |
| 14 | GRK6 | 2.07972018 |
| 15 | LCK | 2.02528153 |
| 16 | MAP3K12 | 1.93856028 |
| 17 | JAK1 | 1.92183299 |
| 18 | FGFR3 | 1.87276016 |
| 19 | TEC | 1.77855710 |
| 20 | CSK | 1.67308393 |
| 21 | PASK | 1.60045173 |
| 22 | NME2 | 1.58421447 |
| 23 | SYK | 1.48646882 |
| 24 | MST4 | 1.48130164 |
| 25 | TBK1 | 1.47130961 |
| 26 | MAP3K14 | 1.42257851 |
| 27 | BLK | 1.32442118 |
| 28 | PRKCH | 1.28820754 |
| 29 | BTK | 1.25861645 |
| 30 | MAP3K11 | 1.21640457 |
| 31 | IRAK4 | 1.20346511 |
| 32 | MAP4K2 | 1.12288488 |
| 33 | PRKCQ | 1.12050166 |
| 34 | HCK | 1.05830869 |
| 35 | PRPF4B | 1.05531676 |
| 36 | HIPK2 | 1.04529164 |
| 37 | MAP3K13 | 0.97202274 |
| 38 | TNK2 | 0.95681236 |
| 39 | CAMKK2 | 0.89962382 |
| 40 | PRKD2 | 0.84742182 |
| 41 | TAOK3 | 0.82727750 |
| 42 | CAMKK1 | 0.82510745 |
| 43 | TGFBR2 | 0.80844822 |
| 44 | IKBKB | 0.80805756 |
| 45 | LYN | 0.77931392 |
| 46 | IRAK1 | 0.76146167 |
| 47 | EPHB1 | 0.75323432 |
| 48 | TESK1 | 0.75306713 |
| 49 | KIT | 0.74251567 |
| 50 | SIK3 | 0.74214330 |
| 51 | ADRBK2 | 0.72066600 |
| 52 | FLT3 | 0.70978157 |
| 53 | MARK3 | 0.70930315 |
| 54 | RIPK1 | 0.68415199 |
| 55 | MAPK15 | 0.68361962 |
| 56 | FGR | 0.67633432 |
| 57 | CHUK | 0.67411236 |
| 58 | MAP2K2 | 0.65975824 |
| 59 | JAK2 | 0.64806570 |
| 60 | MAP3K10 | 0.63510083 |
| 61 | CLK1 | 0.62238593 |
| 62 | TLK1 | 0.62123044 |
| 63 | RPS6KA4 | 0.60966127 |
| 64 | MAP2K3 | 0.59923437 |
| 65 | GRK7 | 0.58735274 |
| 66 | INSRR | 0.58442967 |
| 67 | MAPK11 | 0.56648420 |
| 68 | EPHA3 | 0.55654224 |
| 69 | SCYL2 | 0.54621829 |
| 70 | INSR | 0.53136057 |
| 71 | MARK2 | 0.52999784 |
| 72 | PDGFRB | 0.52289066 |
| 73 | GRK1 | 0.52070803 |
| 74 | PIM1 | 0.50981519 |
| 75 | MAP3K1 | 0.49835734 |
| 76 | ZAK | 0.48778162 |
| 77 | LRRK2 | 0.46770483 |
| 78 | FGFR1 | 0.45782037 |
| 79 | CDK19 | 0.45720859 |
| 80 | NUAK1 | 0.45554087 |
| 81 | IGF1R | 0.42292692 |
| 82 | SIK2 | 0.42255503 |
| 83 | MAPK12 | 0.41715989 |
| 84 | IRAK2 | 0.40456403 |
| 85 | MAPKAPK3 | 0.39895862 |
| 86 | ACVR1B | 0.39620679 |
| 87 | CDK12 | 0.39179032 |
| 88 | MAPKAPK2 | 0.37842281 |
| 89 | MAP3K3 | 0.37115444 |
| 90 | MAPK7 | 0.36369956 |
| 91 | BMPR2 | 0.35552591 |
| 92 | MATK | 0.35065625 |
| 93 | MYLK | 0.32533297 |
| 94 | DAPK1 | 0.31533839 |
| 95 | MAP2K6 | 0.30132363 |
| 96 | PIK3CA | 0.29162861 |
| 97 | MAPK3 | 0.28849745 |
| 98 | CDK9 | 0.28263454 |
| 99 | * FYN | 0.28226968 |
| 100 | PDK1 | 0.27610591 |
| 101 | MAP3K7 | 0.26172534 |
| 102 | MELK | 0.25404701 |
| 103 | PDPK1 | 0.25222136 |
| 104 | BCKDK | 0.24323803 |
| 105 | PTK6 | 0.23527062 |
| 106 | TAOK2 | 0.23062713 |
| 107 | IRAK3 | 0.22984632 |
| 108 | EIF2AK3 | 0.22941296 |
| 109 | DYRK1B | 0.21942579 |
| 110 | ERN1 | 0.21622225 |
| 111 | PRKD3 | 0.21443951 |
| 112 | BRD4 | 0.21282219 |
| 113 | ILK | 0.20592856 |
| 114 | PKN2 | 0.20439799 |
| 115 | EEF2K | 0.19754552 |
| 116 | ABL1 | 0.19274249 |
| 117 | SRPK1 | 0.19049453 |
| 118 | PRKCD | 0.18477766 |
| 119 | TYRO3 | 0.18096692 |
| 120 | STK4 | 0.18056545 |
| 121 | RPS6KA6 | 0.16950025 |
| 122 | CSF1R | 0.16741517 |
| 123 | CDC7 | 0.16263690 |
| 124 | TAOK1 | 0.16217839 |
| 125 | FES | 0.15244840 |
| 126 | STK16 | 0.15194996 |
| 127 | PIK3CG | 0.14931156 |
| 128 | RPS6KA5 | 0.14421336 |
| 129 | PTK2 | 0.13741695 |
| 130 | CDK4 | 0.13302668 |
| 131 | CSNK1G1 | 0.13183937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.28386666 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.02761070 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.46431325 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.40618441 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.21197902 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.97534269 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.90036260 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.83951395 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.80339994 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.36108852 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.30477583 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.18587535 |
| 13 | Protein export_Homo sapiens_hsa03060 | 2.17909087 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.89053578 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73930376 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.71810560 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65067575 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.62877720 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58998062 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.52670846 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.43675322 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43650177 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40588633 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.33725115 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32059243 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21293352 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.18313719 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11971427 |
| 29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11262677 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08711069 |
| 31 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00431004 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98417649 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98009561 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97522177 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97159088 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 0.93992564 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90325633 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 0.89508169 |
| 39 | Proteasome_Homo sapiens_hsa03050 | 0.87627615 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86621923 |
| 41 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86037534 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85748829 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84107676 |
| 44 | RNA degradation_Homo sapiens_hsa03018 | 0.83758414 |
| 45 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82563956 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78255982 |
| 47 | Ribosome_Homo sapiens_hsa03010 | 0.76427682 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75309806 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 0.74956482 |
| 50 | Spliceosome_Homo sapiens_hsa03040 | 0.73974627 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.73205476 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71772414 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71529971 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70065527 |
| 55 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69035256 |
| 56 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64695510 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62169733 |
| 58 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60929618 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60267205 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.60188465 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59007438 |
| 62 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57928917 |
| 63 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.53664416 |
| 64 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.53463344 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.51378829 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50986204 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50379857 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50312724 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.48208542 |
| 70 | Mismatch repair_Homo sapiens_hsa03430 | 0.47283988 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.47185199 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47024648 |
| 73 | RNA polymerase_Homo sapiens_hsa03020 | 0.46103294 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43474363 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.42956562 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.40614820 |
| 77 | Base excision repair_Homo sapiens_hsa03410 | 0.40371405 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.40295553 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.38828342 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38717259 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38509024 |
| 82 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.38041057 |
| 83 | Homologous recombination_Homo sapiens_hsa03440 | 0.37737286 |
| 84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37458476 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37216227 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37113473 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36972340 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36744127 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.36245455 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35226971 |
| 91 | DNA replication_Homo sapiens_hsa03030 | 0.33448925 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33151003 |
| 93 | Phototransduction_Homo sapiens_hsa04744 | 0.32236378 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.31191068 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30482546 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30263220 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29829132 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29037424 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28459695 |
| 100 | Cell cycle_Homo sapiens_hsa04110 | 0.28176804 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.27940709 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26810566 |
| 103 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.25137498 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24769290 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.24263857 |
| 106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.23956578 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21782084 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21586664 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21435682 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.21260969 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20858010 |
| 112 | Insulin secretion_Homo sapiens_hsa04911 | 0.20594379 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20426844 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.19648992 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.19247578 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18135744 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.18122425 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.17738247 |
| 119 | Olfactory transduction_Homo sapiens_hsa04740 | 0.16275243 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14576073 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12136840 |
| 122 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.11232376 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.10132685 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.09904475 |
| 125 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08608977 |
| 126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.08597905 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.07649676 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.07235452 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.05737502 |

